STOCK TITAN

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Optinose (OPTN) to present company overview and business update at 35th Annual Piper Sandler Healthcare Conference on November 29, 2023
Positive
  • None.
Negative
  • None.

YARDLEY, Pa., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the 35th Annual Piper Sandler Healthcare Conference on November 29, 2023, at 3:30 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 60 days following the conclusion of the event.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531


FAQ

What is the event Optinose (OPTN) is participating in?

Optinose (OPTN) will present a company overview and business update at the 35th Annual Piper Sandler Healthcare Conference on November 29, 2023.

When is the presentation taking place?

The presentation will take place on November 29, 2023, at 3:30 p.m. ET.

How can I listen to the presentation live?

To listen to a webcast of the presentation live, visit the Investors page of the Optinose website.

Is there a replay available for the webcast?

Yes, a replay of the webcast will be available for 60 days following the conclusion of the event.

OptiNose, Inc.

NASDAQ:OPTN

OPTN Rankings

OPTN Latest News

OPTN Stock Data

133.95M
82.34M
8.97%
77.6%
2.76%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
YARDLEY

About OPTN

optinose, inc., established in 2010 and headquartered in yardley, pennsylvania, is a publicly traded, global specialty pharmaceutical company focused on serving the needs of patients cared for by ent and allergy specialists. our team of kind, passionate, innovative people is building a new kind of organization without the encumbrances of a company with legacy systems and beliefs. we are unified by a shared mission: to improve lives. we do this while also creating great value for the healthcare system and great outcomes for our stakeholders. as innovators in every aspect of our work, we pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient in all areas of the business. we operate with an overarching commitment to doing what is right. we are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a fo